Precigen (PGEN)
(Delayed Data from NSDQ)
$0.97 USD
+0.03 (3.31%)
Updated Sep 9, 2024 04:00 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Precigen, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -95.90 | 28.32 | -92.17 | -170.52 | -323.92 |
Depreciation/Amortization & Depletion | 15.31 | 13.12 | 26.73 | 37.15 | 25.52 |
Net Change from Assets/Liabilities | 3.40 | -22.70 | -0.80 | -20.65 | 2.43 |
Net Cash from Discontinued Operations | 0.00 | -94.70 | 0.00 | 26.29 | 0.00 |
Other Operating Activities | 10.27 | 10.92 | 10.47 | 50.72 | 160.04 |
Net Cash From Operating Activities | -66.93 | -65.05 | -55.77 | -77.02 | -135.93 |
Property & Equipment | -1.44 | -4.33 | -4.24 | -1.04 | -37.20 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | -7.24 |
Investments | -1.65 | 68.44 | -70.30 | -35.42 | 131.17 |
Other Investing Activities | 0.00 | 162.31 | 0.00 | 64.24 | 0.13 |
Net Cash from Investing Activities | -3.09 | 226.42 | -74.54 | 27.78 | 86.85 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 72.81 | 0.00 | 121.65 | 35.12 | 6.92 |
Issuance (Repayment) of Debt | -43.22 | -155.29 | -0.47 | -0.49 | -0.24 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | -1.92 | 1.46 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 29.59 | -155.29 | 121.19 | 32.71 | 8.14 |
Effect of Exchange Rate Changes | -0.32 | -0.83 | 0.22 | 0.35 | -0.81 |
Net Change In Cash & Equivalents | -40.75 | 5.25 | -8.91 | -16.18 | -41.75 |
Cash at Beginning of Period | 48.60 | 43.34 | 52.25 | 68.43 | 110.18 |
Cash at End of Period | 7.85 | 48.60 | 43.34 | 52.25 | 68.43 |
Diluted Net EPS | -0.39 | 0.14 | -0.47 | -1.02 | -2.09 |
Fiscal Year End for Precigen, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -82.53 | -23.74 | -95.90 | -62.85 | -43.05 |
Depreciation/Amortization & Depletion | 4.25 | 1.20 | 15.31 | 3.82 | 2.74 |
Net Change from Assets/Liabilities | 4.82 | 5.37 | 3.40 | -0.06 | 0.50 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 36.27 | 3.08 | 10.27 | 7.92 | 5.65 |
Net Cash From Operating Activities | -37.20 | -14.09 | -66.93 | -51.16 | -34.16 |
Property & Equipment | -6.67 | -4.35 | -1.44 | -0.43 | -0.19 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 45.67 | 28.39 | -1.65 | -15.95 | -26.71 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 39.00 | 24.05 | -3.09 | -16.38 | -26.91 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.05 | 0.00 | 72.81 | 72.81 | 72.81 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -43.22 | -43.22 | -43.22 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.05 | 0.00 | 29.59 | 29.59 | 29.59 |
Effect of Exchange Rate Changes | -0.10 | -0.06 | -0.32 | -0.31 | -0.17 |
Net Change In Cash & Equivalents | 1.76 | 9.90 | -40.75 | -38.26 | -31.64 |
Cash at Beginning of Period | 7.85 | 7.85 | 48.60 | 48.60 | 48.60 |
Cash at End of Period | 9.61 | 17.74 | 7.85 | 10.34 | 16.95 |
Diluted Net EPS | -0.23 | -0.10 | -0.13 | -0.08 | -0.08 |